ARCHIVES

Neratinib Graduates from I-SPY Phase II Adaptive Trial Regimen

This article is from The Cancer Letter archive.

Vol. 37 No. 4 | April 25, 2014

Download PDF Visit The Full Archive

Related Articles

New Food Technology Could Lower Cancer Risk, Greenwald Says; Nutrition Lab Needed

January 27, 1989

Dana-Farber Picks Rosenthal To Direct New Center For Integrated Therapies.

June 23, 2000

NIH Director Collins Challenged On Capitol Hill Over NCI-Funded Research Linking Tea Party With Tobacco Companies

March 8, 2013

Clearinghouse Finds Insecticide, Hair Dye Are Carcinogens

December 1, 1978

Maryland’s Greenebaum Cancer Center Wins NCI Designation.

September 12, 2008

DePinho Will Not Meet With AAUP In Probe of Tenure Denial Dispute

September 19, 2014